Social Media Influencers Driving Unofficial Trade for Unapproved Slimming Drug
An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has taken down problematic material and banned associated hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.
Online Trading Activities
Research also discovered communities with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
After moments of joining one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.
Product Details and Costs
Inside these communities, messages display black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for Telegram said it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has already seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly significant medical dangers”.